We Think Shareholders May Want To Consider A Review Of NEUCA S.A.'s (WSE:NEU) CEO Compensation Package

Key Insights

• NEUCA's Annual General Meeting to take place on 17th of June
• Salary of zł1.16m is part of CEO Piotr Sucharski's total remuneration
• The overall pay is comparable to the industry average
• NEUCA's three-year loss to shareholders was 2.0% while its EPS was down 3.9% over the past three years

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

NEUCA S.A. (WSE:NEU) has not performed well recently and CEO Piotr Sucharski will probably need to up their game. Shareholders can take the chance to hold the board and management accountable for the unsatisfactory performance at the next AGM on 17th of June. They will also get a chance to influence managerial decision-making through voting on resolutions such as executive remuneration, which may impact firm value in the future. From our analysis, we think CEO compensation may need a review in light of the recent performance.

Check out our latest analysis for NEUCA

Comparing NEUCA S.A.'s CEO Compensation With The Industry

Our data indicates that NEUCA S.A. has a market capitalization of zł3.1b, and total annual CEO compensation was reported as zł2.9m for the year to December 2024. We note that's an increase of 8.5% above last year. We think total compensation is more important but our data shows that the CEO salary is lower, at zł1.2m.

For comparison, other companies in the Poland Healthcare industry with market capitalizations ranging between zł1.5b and zł6.0b had a median total CEO compensation of zł3.8m. This suggests that NEUCA remunerates its CEO largely in line with the industry average. Moreover, Piotr Sucharski also holds zł45m worth of NEUCA stock directly under their own name, which reveals to us that they have a significant personal stake in the company.

Speaking on an industry level, nearly 57% of total compensation represents salary, while the remainder of 43% is other remuneration. In NEUCA's case, non-salary compensation represents a greater slice of total remuneration, in comparison to the broader industry. If total compensation is slanted towards non-salary benefits, it indicates that CEO pay is linked to company performance.

NEUCA S.A.'s Growth

Over the last three years, NEUCA S.A. has shrunk its earnings per share by 3.9% per year. In the last year, its revenue is up 7.0%.

The decline in EPS is a bit concerning. And the modest revenue growth over 12 months isn't much comfort against the reduced EPS. It's hard to argue the company is firing on all cylinders, so shareholders might be averse to high CEO remuneration. Looking ahead, you might want to check this free visual report on analyst forecasts for the company's future earnings..

Has NEUCA S.A. Been A Good Investment?

With a three year total loss of 2.0% for the shareholders, NEUCA S.A. would certainly have some dissatisfied shareholders. This suggests it would be unwise for the company to pay the CEO too generously.

To Conclude...

Along with the business performing poorly, shareholders have suffered with poor share price returns on their investments, suggesting that there's little to no chance of them being in favor of a CEO pay raise. At the upcoming AGM, management will get a chance to explain how they plan to get the business back on track and address the concerns from investors.

Shareholders may want to check for free if NEUCA insiders are buying or selling shares.

Switching gears from NEUCA, if you're hunting for a pristine balance sheet and premium returns, this free list of high return, low debt companies is a great place to look.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.